Delivery Order SPE2DB20D1004-SPE2DB23FE8D1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,100.61 firm fixed-price delivery order is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,480.06 firm fixed price contract is for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a specialty pharmaceutical product, with a completion date of December 1, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,370.52 for the supply of 4560815979 - DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract is a firm-fixed-price agreement with an ultimate completion date of May 4, 2023. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, with an ID of SPE2DX15D3108|SPE2DX23F26GA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,159.82 fixed-price delivery order covers the supply of DUPIXENT 200 MG/1.14 ML SYRING 1.14ML, a specialty pharmaceutical product, with a performance period through May 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $41,935.36 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA). The contract covers the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a period of performance through February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,921.07 fixed-price delivery order is for the pharmaceutical product DUPIXENT 200 MG/1.14 ML PEN 1.14ML, with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order, valued at $28,595.22, is for the procurement of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through December 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,957.05 Firm Fixed Price Delivery Order is for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product, with a performance period through April 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $71,345.01 Firm Fixed Price delivery order contract provides the DLA with DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp (part of parent company Cencora, Inc.) is a Delivery Order valued at $5,926.36 for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 27, 2023. The contract is a Firm Fixed Price Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC, valued at...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FE8D1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,151.25 Firm Fixed Price delivery order is for the supply of DUPIXENT 200 MG/1.14 ML SYRING 1.14ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 2, 2022. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This specific delivery order is awarded under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 11/1/22 |